You have 9 free searches left this month | for more free features.

molecular tumor board

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Trial (Treatment recommendations made by Molecular Tumor Board.)

Not yet recruiting
  • Cancer
  • Treatment recommendations made by Molecular Tumor Board.
  • (no location specified)
Aug 9, 2022

Hematologic Tumors, Solid Tumor Trial in Madison (PMMTB (Precision Medicine Molecular Tumor Board))

Recruiting
  • Hematologic Neoplasms
  • Solid Neoplasm
  • PMMTB (Precision Medicine Molecular Tumor Board)
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jul 7, 2022

Sarcoma Trial in Rome

Recruiting
  • Sarcoma
    • Rome, Italy
      "Regina Elena" National Cancer Institute
    Oct 6, 2023

    NSCLC Trial in Lexington (Molecular tumor board assisted care)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Molecular tumor board assisted care
    • Lexington, Kentucky
      University of Kentucky
    Apr 13, 2022

    Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

    Recruiting
    • Cancer
    • +2 more
    • Cellworks Report
    • Sioux Falls, South Dakota
      Avera Cancer Institute
    Jan 20, 2023

    Physician and Molecular Tumor Board Perspectives on Clinical

    Recruiting
    • Pan-cancer
    • Cellworks Singula and Ventura reports
    • Sioux Falls, South Dakota
      Avera McKennan
    Apr 1, 2022

    Cancer Trial in Lexington (Therapeutic Intervention)

    Recruiting
    • Cancer
    • Therapeutic Intervention
    • Lexington, Kentucky
      Markey Cancer Center, University of Kentucky
    Nov 18, 2022

    Recurrent High Grade Glioma Trial (Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.
    • (no location specified)
    Jul 21, 2022

    Diffuse Intrinsic Pontine Glioma (DIPG) Trial in United States (Specialized tumor board recommendation, Standard radiation

    Completed
    • Diffuse Intrinsic Pontine Glioma (DIPG)
    • Specialized tumor board recommendation
    • Standard radiation therapy
    • San Diego, California
    • +4 more
    Nov 2, 2022

    Solid Tumor, Leukemia Trial in Paris (Solid tumor and CT DNA)

    Recruiting
    • Solid Tumor
    • Leukemia
    • Solid tumor and CT DNA
    • Paris, Villejuif, France
      Gustave Roussy
    Jan 19, 2023

    Cancer, Severe Major Depression, Schizophrenia Trial (Virtual Cancer and Mental Health Tumor Board)

    Not yet recruiting
    • Cancer
    • +8 more
    • Virtual Cancer and Mental Health Tumor Board
    • (no location specified)
    Apr 26, 2023

    Generating Novel Therapeutic Strategies Based on Evolutionary

    Recruiting
    • Incurable Disease
    • Evolutionary Tumor Board (ETB)
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 2, 2022

    Molecular Services and EMR-Lab Integration Application for

    Not yet recruiting
    • Advanced Cancer
    • +2 more
    • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
    • limited genetic testing or no testing
    • Rock Hill, South Carolina
      Carolina Blood and Cancer Care Associates
    Oct 18, 2023

    Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

    Not yet recruiting
    • Endometrial Carcinoma
    • Tumor Molecular Features Screening Model
    • open surgery
    • laparoscopic surgery
    • (no location specified)
    Jun 7, 2023

    Glioma Trial (Blood sampling)

    Not yet recruiting
    • Glioma
    • Blood sampling
    • (no location specified)
    Oct 31, 2023

    Melanoma Trial (Molecular guided therapy)

    Completed
    • Melanoma
    • Molecular guided therapy
    • (no location specified)
    Sep 22, 2021

    Molecular Study and Precision Medicine for Colorectal Cancer

    Not yet recruiting
    • Advanced Colorectal Carcinoma
    • Recurrent Colorectal Carcinoma
    • Molecular Profiling & drug testing in tumor organoids and PDXs
    • Wuhan, Hubei, China
      Wuhan Union Hospital, China
    May 30, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (Best Practice, Chart

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +3 more
    • Best Practice
    • +6 more
    • (no location specified)
    Jul 12, 2022

    Tumor, Solid Trial (Indocyanine Green)

    Not yet recruiting
    • Tumor, Solid
    • Indocyanine Green
    • (no location specified)
    Jan 24, 2023

    Tumor Molecular Profiling in Patients With Prostate Cancer

    Completed
    • Prostate Cancer
    • Metastatic Prostate Adenocarcinoma
    • Tumor molecular profiling
    • Athens, Greece
      Hellenic Cooperative Oncology Group
    Oct 17, 2022

    COGNITION: Genomics-Guided Precision Oncology in Early High-Risk

    Recruiting
    • Early-Stage Breast Cancer
    • Neoadjuvant Therapy
    • Genomic Profiling / Sequencing
    • Berlin, Germany
    • +4 more
    Jun 19, 2023

    Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)

    Active, not recruiting
    • Diffuse Large B Cell Lymphoma
    • Nivolumab, IV, 240 mg
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Jan 3, 2023

    Molecular Profiling in Guiding Individualized Treatment Plan in

    Completed
    • Adult Glioblastoma
    • specialized tumor board recommendation
    • San Francisco, California
      University of California, San Francisco
    Jul 26, 2020

    Sebaceous Cell Tumor of Eyelid Trial in Roma (exome sequencing (retrospective) and exome and methylome sequencing (prospective))

    Recruiting
    • Sebaceous Cell Tumor of Eyelid
    • exome sequencing (retrospective) and exome and methylome sequencing (prospective)
    • Roma, Rome, Italy
      Gustavo Savino
    Oct 8, 2023

    Solid Tumor Trial in Copenhagen (Tumor biopsy)

    Recruiting
    • Unspecified Adult Solid Tumor, Protocol Specific
    • Tumor biopsy
    • Copenhagen, Denmark
      Rigshospitalet
    Oct 25, 2022